Now, Virginia Tech and Agricultural Research Service, USDA researchers have shown that newly developed transgenic yeast used during fermentation will help modify the mycotoxin in the animal feed product to a less toxic form. The research is published online in the September issue of "Biotechnology for Biofuels."
New varieties of hulless winter barley have almost as much starch as corn and can be grown at times and in places where corn cannot, offering a flexible resource. When processed for ethanol, the versatile grain also provides a wholesome animal feed – unless contaminated. Of particular concern are trichothecene mycotoxins, which inhibit protein synthesis, an essential function of all tissues. The result can be immune system suppression and reproductive problems. Animals usually refuse to eat infected grain; otherwise death would be the eventual result.
"So we decided to see if the toxin could be modified to a less toxic product during fermentation," said Piyum A. Khatibi of Long Island, .N.Y., at that time a Ph.D. student in plant pathology, physiology, and weed science in the College of Agriculture and Life Sciences at Virginia Tech.
Khatibi was working on the problem of trichothecene contamination of grains with David Schmale, associate professor of food safety and plant biosecurity in the college, and plant breeder Carl Griffey, professor of crop and soil environmental science in the college. Griffey’s barley team has developed resistant varieties of barley, as well as high starch varieties. The Virginia Tech barley team, made up of Wynse Brooks, research associate; Mark Vaughn, research specialist; and Greg Berger of Schulenburg, Tex., a Ph.D. student, all in crop and soil environmental sciences, has been collaborating with Kevin Hicks, team leader, and John Nghiem, chemical engineer, at the USDA Agricultural Research Service Sustainable Biofuels research team in Wyndmoor, Pa. – a partnership that began in 2001.
The Virginia Tech and USDA researchers decided to go after the most common mycotoxin in barley, deoxynivalenol (DON).
Previous research on a fungus (Fusarium graminearum) that produces DON in barley has identified several genes that convert trichothecenes to less toxic products. The research team selected two of these genes (TRI101 and TRI201), introduced them into a laboratory yeast strain (RW2802), and compared the results to commercial yeast that has been optimized to produce fuel ethanol. The researchers fermented four varieties of barley that Griffey’s team created for biofuel use, hulless Eve and VA06H-25 and hulled Thoroughbred and Price.
Measurements of the resulting mash and animal feed revealed that DON had indeed been converted to a less toxic form (3ADON) during fermentation, with the transgenic yeast expressing either TRI101 or TRI201. The researchers wrote, "We found large reductions in DON via conversion (52.4 percent to 58.1 percent) during fermentation of the hulless barley line VA06H-25, which contained the highest levels of DON in its starting ground grain."
"But in all cases, using the yeast with the added genes resulted in decreased DON as it was converted to the less toxic form (3ADON)," said Khatibi.
"To our knowledge, this is the first detailed report of yeast expressing a DON modification enzyme during barley ethanol fermentation," said Schmale.
Khatibi said, "This study sets the foundation for modifying mycotoxins during fermentation and provides a model for future work when we find an enzyme that can actually destroy the toxin."
The research was supported by Schmale and Griffey's grants from the USDA, Virginia Agriculture Council, and Maryland Grain Producers Utilization Board.
The project was part of Khatibi's dissertation research. He graduated in August and is now a postdoctoral associate working in Schmale's lab continuing his work in mycotoxin detoxification.
The article, " Conversion of deoxynivalenol to 3-acetyldeoxynivalenol in barley derived fuel ethanol co-products with yeast expressing trichothecene 3-O-acetyltransferases," was written by Khatibi; Justin Montanti, engineering technician with the Sustainable Biofuels research team; Nghiem; Hicks; Berger; Brooks; Griffey; and Schmale.
The article is posted at http://www.biotechnologyforbiofuels.com/content/4/1/26
The Schmale lab website is http://www.ppws.vt.edu/~dschmale/
Susan Trulove | Newswise Science News
Microalgae food for honey bees
12.05.2020 | US Department of Agriculture - Agricultural Research Service
Global trade in soy has major implications for the climate
07.05.2020 | Rheinische Friedrich-Wilhelms-Universität Bonn
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering